These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 86719)

  • 21. Metabolic evaluation of patients with stone disease.
    Tiselius HG
    Urol Int; 1997; 59(3):131-41. PubMed ID: 9428428
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of biochemical parameters of blood and urine in spinal cord injury patients and association with urinary stone formation.
    Aydin G; Demir SÖ; Ekiz T; İnanir M; Tosun A
    J Back Musculoskelet Rehabil; 2017 Sep; 30(5):1111-1115. PubMed ID: 28655130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is precipitation of calcium phosphate an important factor for the development of calcium oxalate stones in the urinary tract?
    Tiselius HG
    Front Biosci; 2003 May; 8():s326-32. PubMed ID: 12700064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between experimentally induced crystalluria and relative supersaturation of various stone salts in rats.
    Khan SR; Finlayson B; Thomas WC; Hackett RL
    Urol Res; 1984; 12(6):271-3. PubMed ID: 6523649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both.
    Mo L; Liaw L; Evan AP; Sommer AJ; Lieske JC; Wu XR
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1935-43. PubMed ID: 17898038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on urolithiasis: crystal aggregation in calcium oxalate stone formers (author's transl)].
    Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1981 Jul; 72(7):842-55. PubMed ID: 7321343
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibitors of calcium oxalate crystallization and urolithiasis.
    Grases F; Conte A; Genestar C; Costa-Bauzá A
    Urol Int; 1992; 48(4):409-14. PubMed ID: 1413303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: quantitative studies.
    Rose GA; Sulaiman S
    J Urol; 1982 Jan; 127(1):177-9. PubMed ID: 7057493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uromucoid excretion in normal individuals and stone formers.
    Bichler KH; Ideler V; Harzmann R
    Curr Probl Clin Biochem; 1979; (9):309-24. PubMed ID: 446078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of preincubation of seed crystals of uric acid and monosodium urate with undiluted human urine to induce precipitation of calcium oxalate in vitro : implications for urinary stone formation.
    Grover PK; Ryall RL
    Mol Med; 2002 Sep; 8(9):525-35. PubMed ID: 12456991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis].
    Gambaro G; Baggio B; Favaro S; Cicerello E; Marchini F; Borsatti A
    Nephrologie; 1984; 5(4):171-2. PubMed ID: 6441892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Measurements of urinary macromolecular inhibitory activity of calcium oxalate crystal aggregation].
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):644-51. PubMed ID: 7176279
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanisms of stone formation: role of promoters and inhibitors.
    Fleisch H
    Scand J Urol Nephrol Suppl; 1980; 53():53-66. PubMed ID: 7010571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exclusion mapping of major crystallization inhibitors in idiopathic calcium urolithiasis.
    Cailhier JF; Petrucci M; Valiquette L; Guay G; Ouimet D; Bonnardeaux A
    J Urol; 2001 Oct; 166(4):1484-6. PubMed ID: 11547117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of formation of renal stone crystals.
    Nancollas GH
    Proc Eur Dial Transplant Assoc; 1983; 20():386-97. PubMed ID: 6361752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro system for calcium stone formation: the constant composition model.
    Nancollas GH; Singh RP
    Contrib Nephrol; 1987; 58():49-58. PubMed ID: 3691147
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW; Thorson S; Randolph A
    Trans Am Assoc Genitourin Surg; 1979; 71():62-6. PubMed ID: 161827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique.
    Fan J; Chandhoke PS
    J Urol; 1999 May; 161(5):1685-8. PubMed ID: 10210440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uropontin in urinary calcium stone formation.
    Hoyer JR
    Miner Electrolyte Metab; 1994; 20(6):385-92. PubMed ID: 7783701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.